Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Granules India gets USFDA nod for Fexofenadine Hydrochloride tablets to treat allergy symptoms

      Granules India gets USFDA nod for Fexofenadine Hydrochloride tablets to treat allergy symptoms

      Farhat Nasim21 Oct 2019 10:00 AM IST
      Granules India's Fexofenadine Hydrochloride tablets USP is bio-equivalent to the reference listed drug product (RLD), Allegra Allergy Tablets, 60 mg...
      Ultrasound Equipment now classified as DRUGS, under purview DCA: Gazette notification

      Ultrasound Equipment now classified as DRUGS, under purview DCA: Gazette notification

      Farhat Nasim20 Oct 2019 11:41 AM IST
      New Delhi: Through a recent notification, apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has notified Ultrasound...
      Health Ministry to bring all Medical Devices under CDSCO regulations, Invites comments

      Health Ministry to bring all Medical Devices under CDSCO regulations, Invites comments

      Farhat Nasim19 Oct 2019 5:38 PM IST
      Once finalized, the medical device makers will have to get licences from the Drug Controller General of India (DCGI) while CDSCO will be the nodal...
      USFDA rebukes Torrent Pharma management of inadequacy, violations at multiple sites

      USFDA rebukes Torrent Pharma management of inadequacy, violations at multiple sites

      Farhat Nasim16 Oct 2019 6:20 PM IST
      Repeated failures at multiple sites of Torrent Pharma demonstrate that executive management oversight and control over the manufacture of drugs is...
      Sanofi opens digital biologics manufacturing facility in US

      Sanofi opens digital biologics manufacturing facility in US

      Farhat Nasim16 Oct 2019 9:45 AM IST
      The facility in Framingham accelerates the recent transformation of Sanofi's Industrial Affairs organization to focus on biologics-based therapies, in...
      Abbott, Tandem Diabetes Care explore integrated solutions to improve diabetes management

      Abbott, Tandem Diabetes Care explore integrated solutions to improve diabetes management

      Farhat Nasim16 Oct 2019 9:40 AM IST
      New Delhi: Abbott and Tandem Diabetes Care recently announced that they intend to develop and commercialize integrated diabetes solutions that combine...
      Judge admits making USD 107 million miscalculation in Johnson and Johnson opioid case

      Judge admits making USD 107 million miscalculation in Johnson and Johnson opioid case

      Farhat Nasim16 Oct 2019 9:00 AM IST
      New Delhi: An Oklahoma judge on Tuesday acknowledged making a nearly $107 million miscalculation in determining how much drug maker Johnson &...
      AstraZeneca, Pfizer, Takeda Pharma ink agreement with ImaginAb to develop tumour imaging technology

      AstraZeneca, Pfizer, Takeda Pharma ink agreement with ImaginAb to develop tumour imaging technology

      Farhat Nasim15 Oct 2019 9:45 AM IST
      New Delhi: ImaginAb, Inc., a clinical-stage immuno-oncology imaging company, recently announced the signing of a multi-party collaboration agreement...
      Govt to introduce NEW definition of Medical Devices: Report

      Govt to introduce NEW definition of Medical Devices: Report

      Farhat Nasim14 Oct 2019 4:29 PM IST
      New Delhi: The government is going to adopt another definition of medical devices in order to include more medical equipment under its ambit, a recent...
      Morepen Labs adds blockbuster Rivaroxaban, Vildagliptin, UDCA to API portfolio

      Morepen Labs adds blockbuster Rivaroxaban, Vildagliptin, UDCA to API portfolio

      Farhat Nasim14 Oct 2019 1:36 PM IST
      While two products Rivaroxaban and Vildagliptin will augment Morepen Lab's presence in the cardiac and diabetic segments respectively, the third...
      FIRST: Sun Pharma unveils dry-eye treatment drug CEQUA in US

      FIRST: Sun Pharma unveils dry-eye treatment drug CEQUA in US

      Farhat Nasim14 Oct 2019 1:13 PM IST
      New Delhi: Through a release, drug major, Sun Pharmaceutical Industries Ltd. (Sun Pharma) today announced that one of its wholly-owned subsidiaries...
      JnJ Ebola vaccine to arrive in Congo in November: Health Authorities

      JnJ Ebola vaccine to arrive in Congo in November: Health Authorities

      Farhat Nasim14 Oct 2019 9:00 AM IST
      The JnJ vaccine will complement another vaccine manufactured by Merck, which has been administered to more than 225,000 people. It requires two...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok